Smoking has been linked to more rapid MS progression and greater disease severity but new data suggest oral tobacco use tied to slower disease progression.
New results from one of the largest ever vapour product studies which analysed BATs flagship vapour brand Vuse have been published in the journal of Internal and Emergency Medicine httpslink.springer.comarticle10.1007s11739023032949.
Major study shows adult consumers using BAT's vapour brand Vusei demonstrated significantly better results for biomarkers relevant to smoking-related diseases than smokers Lower levels of